To view this email as a web page, click here.
 
TOP STORIES
 
Seven Most Out-Of-Reach Drugs for Patients Due to High Costs
Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.
Read More
ADVERTISEMENT
 
Independence Blue Cross President: How We Curb the Opioid Epidemic
Philadelphia has the purest and cheapest heroin in the country and a long history of multigenerational heroin addicted families. Here’s what Independence Blue Cross is doing about it.
Read More
ADVERTISEMENT
 
Study Reveals Insurers Could Do More to Cover Opioid Alternatives
A new study was conducted to better understand the landscape of coverage of non-pharmacologic treatments for chronic pain among public and private insurers in the United States. Here’s what it found.
Read more
 
DIGITAL EDITION
Check out our November issue featuring:
 • CAR T-Cell Therapy
 • New C-suite Positions
 • Cancer Care in 10 Years
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.